Delivery Order SPE2DB20D3103-SPE2DB23FP0F4
Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $119
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $230,000 delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 0.6 mg colchicine capsules. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 25 through 28, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested medications to support the Department of Defense's ongoing need to stock...
- The Defense Logistics Agency awarded a $349,210 delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 0.6 mg colchicine tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility under a firm fixed price contract. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports military readiness by procuring and providing supplies in support of various Department of Defense...
- The Defense Logistics Agency awarded a $88,980 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 count bottles of 0.6 mg colchicine tablets. The place of performance is Amerisourcebergen's corporate office and distribution facility located in Conshohocken, Pennsylvania. The order has a period of performance from June 20, 2023 through June 21, 2023 to supply the Defense Logistics Agency's stockpile of this medication used to treat gout attacks. No subcontractors or set...
- The Defense Logistics Agency awarded a $3,332.32 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Colchicine 0.6 mg, with performance in Conshohocken, Pennsylvania and completion by July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This is a $1,017.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 100 tablets of Colchicine 0.6 mg, a medication used to treat gout. The delivery order has an ultimate completion date of July 10, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $23,527.93 delivery order contract to Amerisourcebergen Drug Corp for 4561389183 COLCHICINE 0.6 MG CAPSULE 100S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified pharmaceutical products to the Defense Logistics Agency from its place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. The delivery order was awarded on a non-competitive basis against Amerisourcebergen Drug Corp's existing Prime...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $821.70 to Amerisourcebergen Drug Corp for 100 tablets of Probenecid-Colchicine. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the order. No major subcontractors or set aside designations were identified. The Defense Logistics Agency routinely procures medical supplies and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COLCHICINE 0.6 MG TABLET 100S, with a ceiling value of $1,358.53 and a period of performance extending to May 30, 2025. The contract is not set-aside and was awarded on May 29, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $233.40 to Amerisourcebergen Drug Corporation. The order is for 4561445622 units of 150 mg vials of colistimethate to be delivered to a facility in Conshohocken, Pennsylvania, with performance required between July 10-11, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. The Defense Logistics Agency functions to support...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies. The $1,558.62 order, which did not have a set-aside designation, is part of a larger indefinite delivery contract with the agency to support military treatment programs and facilities. Amerisourcebergen Drug Corp has been a prime contractor for similar...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FP0F4Delivery Order
The Defense Logistics Agency awarded a $118,640 delivery order to Amerisourcebergen Drug Corporation for 100-count bottles of 0.6 mg colchicine tablets. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support the Department of Defense's medical supply needs. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested colchicine tablets on behalf of DLA to facilitate treatment for gout and other conditions within DOD medical treatment facilities. No subcontractors or set aside designations were specified.
Generated 12/23/23, 2:05 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $119 | 7/18/23 |